Posts

Showing posts with the label Warfarin anticoagulants rivaroxaban (Xarelto) dabigatran (Pradaxa) apixaban (Eliquis) andedoxaban Savaysa Lixiana

Growth of the Global Anticoagulants Market

Image
  Some of the main players in the world anticoagulant market are the Bayer Group, BMS / Pfizer, Boehringer Ingelheim, and Daiichi Sankyo, which are the corporate Profiles in the reports. This segment summarizes the overview, the financial overview, and the corporate strategy.    The report also analyzes the available market for injection and oral anticoagulants. In terms of their global sales, the report provides details of  Lovenox ,  Arixtra , Xarelto,  Elicis , Pradaxa, and  Savaysa . The value and sales of the top four oral anticoagulant drugs in the region were also briefly analyzed in the U.S. anticoagulant market.    The most usually prescribed  anticoagulant  is Warfarin. More up-to-date sorts of anticoagulants are likewise accessible and are getting progressively normal. These incorporate  rivaroxaban (Xarelto ) , dabigatran (Pradaxa),  apixaban (Eliquis ), and  edoxaban  ( Savaysa / Lixiana ). Warfarin and the more current options are taken as tablets or containers.  There is